Cambrex Corporation, the leading manufacturer of small molecule innovator and generic active pharmaceutical ingredients (APIs), has completed the installation of multiple continuous flow reactor platforms at its High Point (NC, USA) facility
More From BioPortfolio on "Cambrex invests in new continuous flow technology at its High Point (NC, USA) facility"